Cardiol Therapeutics Inc. ( CRDL) - Stock Earnings
CRDL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -5.3 million USD | — USD |
| 2026Q1 | -7.8 million USD | — USD |
| 2026Q2 | -6.1 million USD | — USD |
| 2026Q4 Est. | — | — |
CRDL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -16.0 million USD | — USD |
| 2024 | -25.5 million USD | — USD |
| 2025 | -24.7 million USD | — USD |
| 2026 Est. | — | — |
CRDL
Price: $1.32
52 week price:
Earnings Per Share: -0.25 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 88200
Market Capitalization: 248.4 million